Insulinoma

USMLE Step 1 trap: Forgets that C-peptide is co-secreted with endogenous insulin, so insulinoma raises both while exogenous insulin suppresses C-peptide. Insulinoma produces elevated insulin with elevated C-peptide; low C-peptide with high insulin indicates exogenous insulin administration.

Insulinoma is a functioning beta-cell tumor that secretes insulin autonomously and causes recurrent fasting hypoglycemia. USMLE Step 1 tests it from several angles, and the highest-yield trap is C-peptide interpretation: students routinely reverse which direction C-peptide goes in insulinoma versus exogenous insulin injection — elevated insulin with elevated C-peptide means endogenous secretion (insulinoma), while elevated insulin with suppressed C-peptide means the patient is injecting insulin and suppressing their own pancreas. The exam also tests Whipple triad and the MEN1 association.

The trickiest part of insulinoma on Step 1 is the C-peptide question. Students routinely mix up which direction C-peptide goes in insulinoma versus exogenous insulin administration. Remember: C-peptide is cleaved from proinsulin during endogenous insulin synthesis, so any tumor secreting real insulin secretes C-peptide too — both go up. Someone injecting insulin externally suppresses their own pancreatic output, so C-peptide drops. This is the key lab that separates factitious hypoglycemia from an actual tumor, and the exam loves to test it.

The second common gap is incomplete knowledge of Whipple triad. Students often remember 'low glucose' but can't name all three components precisely. On USMLE Step 1, vignettes will describe a patient who feels better after eating or after glucose administration — that relief is the third component, and missing it means missing the diagnosis or the clinical reasoning the question is driving at.

From real student decks

70%have cards covering this topic

43%have mature cards

Common misconceptions

Common mistake

Wrong: Elevated insulin with low C-peptide confirms insulinoma.

Right: Insulinoma produces elevated insulin with elevated C-peptide; low C-peptide with high insulin indicates exogenous insulin administration.

C-peptide is produced in a 1:1 molar ratio with endogenous insulin because it's cleaved from the same proinsulin molecule — so any tumor making insulin makes C-peptide too, and both will be elevated. When someone injects exogenous insulin, their blood glucose drops, which suppresses their own pancreatic beta cells, driving C-peptide down even as exogenous insulin levels rise. So elevated insulin + elevated C-peptide = endogenous source (insulinoma or sulfonylurea use); elevated insulin + low C-peptide = exogenous insulin injection. If a vignette gives you high insulin and low C-peptide, think factitious hypoglycemia, not insulinoma.

Common mistake

Gap: Missing the three components of Whipple triad required to diagnose insulinoma clinically

Whipple triad for insulinoma consists of symptomatic hypoglycemia, documented low serum glucose during symptoms, and relief of symptoms with glucose administration.

Whipple triad has three specific components and you need all three: (1) symptoms consistent with hypoglycemia (confusion, diaphoresis, palpitations), (2) documented low serum glucose during those symptoms — not just a low glucose at some other time, and (3) relief of symptoms upon glucose administration. The third component is the one students most often drop. It matters because it confirms the symptoms were actually caused by the hypoglycemia, not by some coincidental process. A Step 1 vignette will often describe a patient whose symptoms resolve after eating or after IV dextrose — that's the clinical cue pointing you toward insulinoma.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Recognize the classic presentation of insulinoma using Whipple triad: symptoms of hypoglycemia, documented low serum glucose during those symptoms, and symptom relief after glucose is given.
Interpret the 72-hour supervised fasting test results — elevated insulin and elevated C-peptide with hypoglycemia confirms endogenous insulin excess (insulinoma), while elevated insulin with suppressed C-peptide points to exogenous insulin use; also know that a sulfonylurea screen is included to rule out drug-induced hypoglycemia.
Select the appropriate management: surgical resection is the definitive treatment, diazoxide or octreotide bridges patients preoperatively, and all patients with insulinoma should be screened for MEN1 (which also includes parathyroid and pituitary tumors).

Can you avoid these mistakes?

A 45-year-old woman has episodes of confusion and diaphoresis that occur before breakfast and resolve after eating. Her glucose during an episode is 42 mg/dL. What are the three components of Whipple triad, and does this patient satisfy all of them?

During a 72-hour fast, a patient develops symptomatic hypoglycemia. Labs show glucose 38 mg/dL, insulin elevated, and C-peptide suppressed. What does this pattern indicate, and how does it differ from the expected insulinoma pattern?

A patient is diagnosed with insulinoma and undergoes surgical resection. What additional syndrome should you screen for, and what other organ systems are involved in that syndrome?

A vignette describes a nurse with recurrent hypoglycemic episodes. Labs show high insulin and low C-peptide. A sulfonylurea screen is negative. What is the most likely diagnosis, and what is the mechanism behind the C-peptide result?

Insulinoma

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics